Minimal Effects of Cariprazine on Prolactin Levels in Bipolar Disorder and Schizophrenia

BACKGROUND: Many medications used to treat schizophrenia and bipolar I disorder are linked to hyperprolactinemia. The effects of cariprazine, a dopamine D(3)/D(2) receptor partial agonist, on prolactin levels in patients with schizophrenia or bipolar I disorder were evaluated. METHODS: Effects on pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Culpepper, Larry, Vieta, Eduard, Kelly, Deanna L, Patel, Mehul D, Szatmári, Balázs, Hankinson, Arlene, Earley, Willie R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112044/
https://www.ncbi.nlm.nih.gov/pubmed/35591886
http://dx.doi.org/10.2147/NDT.S348143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112044/
https://www.ncbi.nlm.nih.gov/pubmed/35591886
http://dx.doi.org/10.2147/NDT.S348143

Ejemplares similares